AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 15810623
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg bid
Trial: 15810623
Drug: Patients with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients with antibiotic resistance
Trial: 10203371
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human erythropoietin (rhEPO) therapy
Trial: 8652974
Drug: Hyperimmune bovine
RxNorm normalized name: Cryptosporidium hyperimmune bovine colostrum IgG
DrugBank: Cryptosporidium immune globulin (DB17785)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperimmune bovine colostrum (HBC) 100 ml three times a day for 3 consecutive days
Trial: 2181565
Drug: nifedipine (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nifedipine (40 mg/day)
Trial: 2181565
Drug: low salt
FDA approved: no
EMA approved: no
PMDA approved: no
Description: low salt diet (5 g of salt/day) and nifedipine
Trial: 2181565
Drug: low salt
FDA approved: no
EMA approved: no
PMDA approved: no
Description: low salt diet (5 g of salt/day), nifedipine and a salt supplement (6 g/day)
Trial: 2181565
Drug: unrestricted diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: unrestricted diet and nifedipine (40 mg/day)
Trial: 2181565
Drug: unrestricted diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: unrestricted diet and medication
Trial: 2181565
Drug: low salt
FDA approved: no
EMA approved: no
PMDA approved: no
Description: low salt diet (5 g of salt/day)
Trial: 6379629
Drug: Cimetidine therapy
RxNorm normalized name: Cimetidine
DrugBank: Cimetidine (DB00501)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cimetidine therapy
Trial: 28418102
Drug: solifenacin 5
RxNorm normalized name: solifenacin 5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: solifenacin 5 mg + mirabegron 25 mg (combined S5 + M25 group)
Trial: 28418102
Drug: solifenacin 5
RxNorm normalized name: solifenacin 5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: solifenacin 5 mg + mirabegron 50 mg (combined S5 + M50 group)
Trial: 26663687
Drug: mirabegron 25
RxNorm normalized name: mirabegron 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mirabegron 25 mg
Trial: 21094194
Drug: Eating rate
RxNorm normalized name: tacrolimus
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eating rate of foods (g/min)
Trial: 26147635
Drug: Topical pimecrolimus
RxNorm normalized name: pimecrolimus Topical Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical pimecrolimus 1% cream
Trial: 18677657
Drug: Topical ketoconazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical ketoconazole 2% cream
Trial: 17557047
Drug: Various endoscopic
RxNorm normalized name: various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Various endoscopic therapies for GERD
Trial: 15286958
Drug: SS (supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SS (supplements both before and after surgery)
Trial: 15286958
Drug: CS (postoperative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CS (postoperative supplements only)
Trial: 15286958
Drug: CC (no
RxNorm normalized name: INV-COVID-19 VACC (NOVAVAX) INJ 5ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CC (no nutritional supplements)
Trial: 15286958
Drug: SC (supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SC (supplements only before surgery)
Trial: 11150359
Drug: Dexamethasone (0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (0.15 mg/kg/day for 3 days, followed by tapering over 7 days)
Trial: 9744982
Drug: Oral Contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Contraceptive Pill (OCP)
Trial: 7877205
Drug: Nadolol (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nadolol (80 mg orally)
Trial: 7877205
Drug: Isosorbide‐5‐mononitrate (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isosorbide‐5‐mononitrate (20 mg orally)
Trial: 7877205
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy with nadolol and isosorbide‐5‐mononitrate
Trial: 7877205
Drug: Nadolol (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nadolol (80 mg orally) followed by isosorbide‐5‐mononitrate
Trial: 14594148
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg oral methadone (5 mg bd)
Trial: 14594148
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg oral methadone (10 mg bd)
Trial: 10885044
Drug: Free treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Free treatment (90 days of substance abuse treatment)
Trial: 10885044
Drug: Free treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Free treatment
Trial: 10885044
Drug: Paid treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paid treatment
Trial: 9374236
Drug: Green tea
RxNorm normalized name: Green Tea
DrugBank: Green tea leaf (DB14307)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Green tea 3.6 g per day
Trial: 9374236
Drug: Green tea
RxNorm normalized name: Green Tea
DrugBank: Green tea leaf (DB14307)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Green tea 5.4 g per day
Trial: 2989571
Drug: Ensure (0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ensure (0 g/day soy fiber)
Trial: 2989571
Drug: Enrich (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enrich (30 g/day soy fiber)
Trial: 2989571
Drug: Ensure with
RxNorm normalized name: Ensure with Fiber Vanilla
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ensure with 30 g/day soy fiber (diet c)
Trial: 2989571
Drug: Ensure with
RxNorm normalized name: Ensure with Fiber Vanilla
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ensure with 60 g/day soy fiber (diet d)
Trial: 24485347
Drug: Individual Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individual Therapy (IP)
Trial: 17996819
Drug: Continuous aortic
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous aortic flow augmentation using the Orqis Medical Cancion System (up to 1.5 L/min)
Trial: 17996819
Drug: Continuous aortic
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous aortic flow augmentation
Trial: 10356077
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid group (low in folate, approximately 210 micrograms of folate plus 250 micrograms of folic acid daily)
Trial: 10356077
Drug: Placebo group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo group (same low-folate diet as the folic acid group plus placebo tablet)
Trial: 1673133
Drug: Intravenous metoprolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous metoprolol (15 mg)
Trial: 7471621
Drug: Methapyrilene 20
RxNorm normalized name: methapyrilene
DrugBank: Methapyrilene (DB04819)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methapyrilene 20 mg intravenously
Trial: 7471621
Drug: Methapyrilene 50
RxNorm normalized name: methapyrilene
DrugBank: Methapyrilene (DB04819)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methapyrilene 50 mg orally
Trial: 7471621
Drug: Methapyrilene 25
RxNorm normalized name: methapyrilene 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methapyrilene 25 mg orally
Trial: 24393328
Drug: Dexamethasone (16-16-12-12-8-4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (16-16-12-12-8-4 mg/d)
Trial: 23032160
Drug: Tetanus monovalent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tetanus monovalent vaccine (TMV; Vaccin Tétanique Pasteur® or Tetavax®)
Trial: 23032160
Drug: Tetanus monovalent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tetanus monovalent vaccine (TMV)
Trial: 17457706
Drug: ia 20
RxNorm normalized name: ammonia 20 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ia 20 ml of 0.25 % bupivacaine at the end of the operation
Trial: 17457706
Drug: ia 20
RxNorm normalized name: ammonia 20 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ia 20 ml of 0.25 % bupivacaine and 100 mg of tramadol at the end of the operation
Trial: 17457706
Drug: ia 100
RxNorm normalized name: Januvia 100mg Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ia 100 mg of tramadol diluted in 20 ml of saline solution 30 minutes before skin incision and 20 ml of 0.25% bupivacaine at the end of the operation
Trial: 9615981
Drug: 3 x
RxNorm normalized name: Xenon (133 xe)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 x 500 impulses of low‐energetic extracorporal shock‐wave therapy
Trial: 9615981
Drug: 3 x
RxNorm normalized name: Xenon (133 xe)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 x 100 impulses of low‐energetic extracorporal shock‐wave therapy
Trial: 355810
Drug: Heparin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin (100 international units per kilogram of body weight, subcutaneously every eight hours for two weeks)
Trial: 31994374
Drug: Artichoke leaves
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Artichoke leaves and ginger root extracts combination (320 mg) + simethicone (40 mg)
Trial: 26401986
Drug: High-dose vitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose vitamin D (50,000 IU every 5 days for 3 months)
Trial: 20103833
Drug: Oral midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral midazolam 0.5 mg/kg (group M)
Trial: 17543634
Drug: Tolvaptan (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolvaptan (30 mg/day)
Trial: 8343002
Drug: Dual-lumen 10
RxNorm normalized name: Luden's Dual Relief
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual-lumen 10 French tunneled cuffed silastic central venous access catheter with a second proximal subcutaneous silver-impregnated cuff
Trial: 27901218
Drug: Fluid solutions
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluid solutions
Trial: 22607269
Drug: Single doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single doses of S1RA (5-500 mg, study 101; 500-800 mg, study 106)
Trial: 22607269
Drug: Multiple doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple doses of S1RA (50-400 mg once daily for 8 days, study 102)
Trial: 18590952
Drug: Fenfluramine administration
RxNorm normalized name: fenfluramine
DrugBank: Fenfluramine (DB00574)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenfluramine administration in MDD/AUD group
Trial: 12215958
Drug: Intravenous L-arginine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous L-arginine hydrochloride salt
Trial: 9641434
Drug: Naproxen (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen (500 mg orally twice per day)
Trial: 15378949
Drug: alpha-interferon (alpha-IFN)
RxNorm normalized name: Interferon alpha-2B
DrugBank: Interferon alfa-2b (DB00105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: alpha-interferon (alpha-IFN) administered at a dose of 3 x 10(6) U three times per week until disease progression.
Trial: 15378949
Drug: No therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No therapy (control group) for patients who obtained a complete or partial response after FLU therapy.
Trial: 1099894
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g D-isoascorbic acid
Trial: 2110943
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g L-ascorbic acid
Trial: 31773143
Drug: Fidaxomicin (suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fidaxomicin (suspension or tablets, twice daily for 10 days)
Trial: 31773143
Drug: Vancomycin (suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vancomycin (suspension or tablets, 4 times daily for 10 days)
Trial: 26399399
Drug: Verum acupuncture
RxNorm normalized name: Cinnamomum verum whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verum acupuncture plus as-needed salbutamol aerosol and/or prednisone tablets
Trial: 26399399
Drug: Sham acupuncture
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham acupuncture plus as-needed salbutamol aerosol and/or prednisone tablets
Trial: 23290835
Drug: VPM1002 (Mycobacterium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VPM1002 (Mycobacterium bovis BCG ΔureC::hly Hm(R)), administered as one intradermal dose, randomized to three escalating doses.
Trial: 7714143
Drug: Intravenous immunoglobulin
RxNorm normalized name: Intravenous immunoglobulin (IVIg)
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous immunoglobulin (Ig) 500 mg/kg prior to the next embryo transfer
Trial: 3443063
Drug: Felodipine 10mg
RxNorm normalized name: FELODIPINE 10MG TAB,SA
DrugBank: Felodipine (DB01023)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Felodipine 10mg single dose
Trial: 3443063
Drug: Felodipine (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felodipine (various doses)
Trial: 31248662
Drug: Veverimer (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Veverimer (6 g/day)
Trial: 29235659
Drug: Open‐label, protocolized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Open‐label, protocolized treatment with extended‐release venlafaxine for 12 or more weeks
Trial: 25145693
Drug: High-dose oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose oral methylprednisolone (oMP)
Trial: 19015193
Drug: Saline injection
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline injection (5K(Plac), L3‐L4)
Trial: 11549975
Drug: Low-dose fluticasone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose fluticasone propionate (176 or 200 mcg daily) for 6‐26 weeks
Trial: 11549975
Drug: Low-dose fluticasone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose fluticasone propionate (100 mcg daily) for 12‐52 weeks
Trial: 11549975
Drug: Low-dose beclomethasone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose beclomethasone dipropionate (336 mcg daily)
Trial: 7964957
Drug: Interferon alfa
RxNorm normalized name: Interferon alfa
DrugBank: Interferon alfa (DB05258)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon alfa 3 MU three times weekly
Trial: 7964957
Drug: IFN alfa
RxNorm normalized name: IFN Alfacon-1
DrugBank: Interferon alfacon-1 (DB00069)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFN alfa 5 MU three times weekly plus DEX
Trial: 7964957
Drug: Higher dose-intensity
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Higher dose-intensity glucocorticoids
Trial: 3655306
Drug: Repeated paracentesis
RxNorm normalized name: eicosyl povidone (2 eicosyl branches-repeat)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repeated paracentesis plus i.v. albumin infusion (n = 20)
Trial: 3655306
Drug: Diuretics (n
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diuretics (n = 21)
Trial: 29788137
Drug: TELE‐IBD W
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TELE‐IBD W (weekly)
Trial: 22519127
Drug: Inhaled fluticasone/salmeterol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled fluticasone/salmeterol (group A)
Trial: 22519127
Drug: Inhaled budesonide/formoterol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled budesonide/formoterol (group B)
Trial: 20691689
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg CDC
Trial: 20691689
Drug: 1000 mg
RxNorm normalized name: bran 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg CDC
Trial: 16538529
Drug: Tamoxifen (Tam)
DrugBank: Tamoxifen (DB00675)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tamoxifen (Tam) 20 mg per day orally for 5 years
Trial: 16538529
Drug: Tamoxifen (Tam)
DrugBank: Tamoxifen (DB00675)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tamoxifen (Tam) plus Fluoxymesterone (Flu) 10 mg orally twice per day for 1 year
Trial: 12654164
Drug: Isolated isoflavone
RxNorm normalized name: ISOLATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isolated isoflavone supplement (86 mg/d, derived from red clover)
Trial: 31049414
Drug: Enhanced care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enhanced care at public health facilities including clinical care guides, drugs for COPD, patient education flipcharts, staff training, and mobile phone follow-up.
Trial: 28118538
Drug: Peficitinib 50
RxNorm normalized name: peficitinib
DrugBank: Peficitinib (DB11708)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Peficitinib 50 mg
Trial: 28118538
Drug: Peficitinib 100
RxNorm normalized name: peficitinib
DrugBank: Peficitinib (DB11708)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Peficitinib 100 mg
Trial: 28118538
Drug: Peficitinib 150
RxNorm normalized name: peficitinib
DrugBank: Peficitinib (DB11708)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Peficitinib 150 mg
Trial: 26672064
Drug: All peficitinib
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All peficitinib doses (25, 50, 100, 150 mg)
Trial: 28118538
Drug: Peficitinib 25
RxNorm normalized name: peficitinib
DrugBank: Peficitinib (DB11708)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Peficitinib 25 mg
Trial: 17628451
Drug: LDE tablet
RxNorm normalized name: LANCET,STERILANCE LDE 2 DEVICE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LDE tablet of griseofulvin (125mg)
Trial: 17628451
Drug: Immediate release
RxNorm normalized name: Namenda, immediate release oral kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate release conventional tablet of griseofulvin (125mg)
Trial: 14556131
Drug: Neostigmine 1
RxNorm normalized name: neostigmine 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neostigmine 1 mg added to 3 mg/kg of 0.5% lidocaine (maximum 45 mL)
Trial: 14556131
Drug: No additives
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No additives to the IVRA solution (Control group)
Trial: 10364900
Drug: SASP 2000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SASP 2000 (maximum 3000) mg daily (n = 68)
Trial: 10364900
Drug: MTX 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MTX 7.5 (maximum 15) mg weekly (n = 69)
Trial: 9345416
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose intravenous immunoglobulin (IVIG)
Trial: 27221477
Drug: Artificial cycle
RxNorm normalized name: COLOR,ARTIFICIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Artificial cycle with GnRH-agonist (n=118)
Trial: 22189672
Drug: EGb 761®
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EGb 761® 120 mg twice daily
Trial: 22189672
Drug: EGb 761®
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EGb 761® 240 mg once daily
Trial: 20629597
Drug: Mometasone furoate
RxNorm normalized name: Mometasone Furoate
DrugBank: Mometasone furoate (DB14512)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mometasone furoate nasal spray (MFNS) 100 microg daily for 4 weeks
Trial: 11795350
Drug: Raloxifene (selective
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raloxifene (selective estrogen receptor modulator)
Trial: 9018407
Drug: Water‐Del (metered:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Water‐Del (metered: 200 ml water every 15 min)
Trial: 18296460
Drug: Antioxidants (selenium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidants (selenium 10 mug, zinc 5 mg, vitamin A 0.9 mg, vitamin E 100 mg, vitamin C 50 mg)
Trial: 18296460
Drug: Folinic acid
RxNorm normalized name: Folinic acid
DrugBank: Leucovorin (DB00650)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Folinic acid (0.1 mg)
Trial: 12709801
Drug: Faropenem daloxate
RxNorm normalized name: Faropenem daloxate
DrugBank: Faropenem medoxomil (DB05659)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Faropenem daloxate (300 mg, twice daily for 7 days)
Trial: 12709801
Drug: Cefuroxime axetil
RxNorm normalized name: Cefuroxime Axetil
DrugBank: Cefuroxime (DB01112)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefuroxime axetil (250 mg, twice daily for 7 days)
Trial: 9112443
Drug: Pion therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pion therapy (33-34.5 Gy pi)
Trial: 1287620
Drug: Cefaclor AF
RxNorm normalized name: Cefaclor
DrugBank: Cefaclor (DB00833)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefaclor AF 500 mg once daily (at night)
Trial: 1287620
Drug: Cefaclor 250
RxNorm normalized name: cefaclor 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefaclor 250 mg three times a day
Trial: 1287620
Drug: Cefaclor AF
RxNorm normalized name: Cefaclor
DrugBank: Cefaclor (DB00833)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefaclor AF (375 mg and 500 mg)
Trial: 6961477
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg PGE2 in viscous gel
Trial: 26272450
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg oral fimasartan (FMS)
Trial: 26272450
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg intravenous (IV) fimasartan (FMS)